Russell Investments Group
MRNA icon

Russell Investments Group’s Moderna MRNA Stock Holding History

Russell Investments Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3M Sell
447,448
-263,192
-37% -$13.6M 0.03% 562
2026
Q1 		$36.1M Buy
710,640
+363,492
+105% +$17M 0.04% 459
2025
Q4 		$10.2M Buy
347,148
+59,445
+21% +$1.62M 0.01% 898
2025
Q3 		$7.43M Buy
287,703
+131,663
+84% +$3.67M 0.01% 1067
2025
Q2 		$4.3M Sell
156,040
-3,623
-2% -$95.4K 0.01% 1310
2025
Q1 		$4.56M Sell
159,663
-10,580
-6% -$375K 0.01% 1221
2024
Q4 		$7.02M Buy
170,243
+76,350
+81% +$3.65M 0.01% 991
2024
Q3 		$6.25M Buy
93,893
+23,721
+34% +$2.18M 0.01% 1069
2024
Q2 		$8.4M Buy
70,172
+4,922
+8% +$623K 0.01% 901
2024
Q1 		$7.07M Sell
65,250
-1,804
-3% -$182K 0.01% 1004
2023
Q4 		$6.65M Sell
67,054
-26,430
-28% -$2.22M 0.01% 992
2023
Q3 		$9.58M Sell
93,484
-5,253
-5% -$586K 0.02% 769
2023
Q2 		$12M Sell
98,737
-6,708
-6% -$895K 0.02% 689
2023
Q1 		$16M Sell
105,445
-7,947
-7% -$1.31M 0.03% 597
2022
Q4 		$20.3M Sell
113,392
-7,627
-6% -$1.25M 0.04% 493
2022
Q3 		$14.3M Buy
121,019
+24,643
+26% +$3.74M 0.03% 617
2022
Q2 		$13.8M Buy
96,376
+7,807
+9% +$1.12M 0.03% 649
2022
Q1 		$15.3M Sell
88,569
-13,317
-13% -$2.24M 0.03% 647
2021
Q4 		$25.8M Buy
101,886
+9,188
+10% +$2.69M 0.04% 514
2021
Q3 		$35.5M Buy
92,698
+12,814
+16% +$4.73M 0.06% 384
2021
Q2 		$18.8M Buy
79,884
+3,475
+5% +$621K 0.03% 631
2021
Q1 		$9.65M Buy
76,409
+6,067
+9% +$879K 0.02% 966
2020
Q4 		$7.58M Buy
70,342
+27,332
+64% +$2.77M 0.02% 1021
2020
Q3 		$3.04M Sell
43,010
-11,684
-21% -$815K 0.01% 1421
2020
Q2 		$3.49M Buy
54,694
+53,379
+4,059% +$2.92M 0.01% 1311
2020
Q1 		$39K Buy
+1,315
New +$30.3K ﹤0.01% 2893

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Russell Investments Group's MRNA Position: Q2 2026 in Review

Russell Investments Group reduced its Moderna (MRNA) stake by 37% in Q2 2026, selling an estimated $13.6M and leaving 447,448 shares worth $31.3M. The position accounts for 0.03% of the portfolio, ranked #562.

Russell Investments Group first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $36.1M in Q1 2026. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Russell Investments Group held 447,448 shares of Moderna worth $31.3M as of Q2 2026.
  • Russell Investments Group sold 263,192 Moderna shares in Q2 2026, an estimated $13.6M.
  • Moderna made up 0.03% of Russell Investments Group's portfolio in Q2 2026, its #562 holding.
  • Russell Investments Group first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Russell Investments Group's Moderna position peaked at $36.1M in Q1 2026.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.